42‐1: Invited Paper: Commercial Readiness of High‐Performance Cadmium‐Free Quantum Dot Inks for MicroLED Color Conversion Applications
SID Symposium Digest of Technical Papers · 2026-08 · 57 (S1) · 387-389
DOI: 10.1002/sdtp.70003_102 ↗Kurz gefasst
Fachartikel in der Zeitschrift SID Symposium Digest of Technical Papers, online erschienen am 11.09.2026. Verfasst von Alasdair Brown und 5 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Quantum Dots (QDs) are well‐established in the display industry, primarily through their application in LCD TVs and, more recently, in QD‐OLED displays. However, challenges related to obtaining high‐performance, commercially viable QD inks have historically restricted their adoption in emerging applications, such as MicroLED displays. QustomDot presents its significant progress in developing commercially ready, cadmium‐free (Cd‐free) QD ink specifically engineered for Quantum Dot Color Conversion (QDCC) in MicroLED technologies.
Zitieren
APA
Brown, A., Kiaee, M., Grigel, V., Nakonechnyi, I., Benamar, I., & Nolf, K. D. (2026). 42‐1: Invited Paper: Commercial Readiness of High‐Performance Cadmium‐Free Quantum Dot Inks for MicroLED Color Conversion Applications. SID Symposium Digest of Technical Papers, 57(S1), 387-389. https://doi.org/10.1002/sdtp.70003_102
Vancouver
Brown A, Kiaee M, Grigel V, Nakonechnyi I, Benamar I, Nolf KD. 42‐1: Invited Paper: Commercial Readiness of High‐Performance Cadmium‐Free Quantum Dot Inks for MicroLED Color Conversion Applications. SID Symposium Digest of Technical Papers. 2026;57(S1):387-389. doi:10.1002/sdtp.70003_102
BibTeX
@article{Brown2026,
author = {Brown, Alasdair and Kiaee, Mohammad and Grigel, Valeriia and Nakonechnyi, Igor and Benamar, Imane and Nolf, Kim De},
title = {42‐1: Invited Paper: Commercial Readiness of High‐Performance Cadmium‐Free Quantum Dot Inks for MicroLED Color Conversion Applications},
journal = {SID Symposium Digest of Technical Papers},
year = {2026},
volume = {57},
number = {S1},
pages = {387--389},
doi = {10.1002/sdtp.70003_102}
}
EUVIMED